112 results on '"Kalua Khumbo"'
Search Results
102. Blindness in Childhood in Developing Countries: Time for a Reassessment?
- Author
-
Gogate, Parikshit, primary, Kalua, Khumbo, additional, and Courtright, Paul, additional
- Published
- 2009
- Full Text
- View/download PDF
103. Baseline Trachoma Mapping in Malawi with the Global Trachoma Mapping Project (GTMP).
- Author
-
Kalua, Khumbo, Phiri, Menard, Kumwenda, Isaac, Masika, Michael, Pavluck, Alexandre L., Willis, Rebecca, Mpyet, Caleb, Lewallen, Susan, Courtright, Paul, and Solomon, Anthony W.
- Subjects
- *
BLINDNESS , *VISION disorders , *DISEASE prevalence , *CHLAMYDIA infections , *TRACHOMA , *CONJUNCTIVA diseases , *DIAGNOSIS - Abstract
Purpose: To determine the prevalence of trachoma in all suspected endemic districts in Malawi. Methods: A population-based survey conducted in 16 evaluation units from 12 suspected endemic districts in Malawi (population 6,390,517), using the standardized Global Trachoma Mapping Project (GTMP) protocol. A 2-stage cluster-random sampling design selected 30 households from each of 30 clusters per evaluation unit; all residents aged 1 year and older in selected households were examined for evidence of follicular trachoma (TF), intense trachomatous inflammation (TI), and trachomatous trichiasis (TT). Results: Four of the 16 evaluation units were found to be endemic for trachoma, with a prevalence range of 10.0-13.5% for TF and 0.2-0.6% for TT. Nine evaluation units had a TF prevalence between 5.0% and 9.9% while three evaluation units had a TF prevalence <5.0%. Conclusion: The prevalence rates of active trachoma in Malawi were not uniform among suspected endemic evaluation units, with rates higher than the World Health Organization (WHO) threshold for implementation of community-based control measures (TF ≥ 10.0%) in only 4 of the 16 evaluation units. Trachoma remains a disease of public health importance in some parts of Malawi and adjoining (unmapped) districts should be prioritized for mapping. According to the survey, an additional 3,169,362 people require intervention to reduce active disease and 1557 trichiasis surgeries are needed to reduce the prevalence of TT below WHO recommended thresholds. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
104. How to create a balanced eye team: an example from Malawi.
- Author
-
Kalua, Khumbo
- Subjects
- *
EYE care , *HEALTH care teams , *INFORMATION resources - Published
- 2018
105. Coverage of community-wide mass drug administration platforms for soil-transmitted helminths in Benin, India, and Malawi: findings from the DeWorm3 project.
- Author
-
Means AR, Ásbjörnsdóttir KH, Sharrock KC, Galagan SR, Aruldas K, Avokpaho E, Chabi F, Halliday KE, Houngbegnon P, Israel GJ, Kaliappan SP, Kennedy D, Legge H, Oswald WE, Palanisamy G, Rogers E, Timothy J, Pearman E, Ramesh RM, Simwanza J, Sheik-Abdullah JF, Sheikh M, Togbevi CI, Witek-McManus S, Pullan RL, Bailey R, Kalua K, Ibikounlé M, Luty AJF, Ajjampur SSR, and Walson JL
- Subjects
- Humans, Malawi epidemiology, Female, Male, Benin epidemiology, India epidemiology, Child, Adolescent, Adult, Young Adult, Child, Preschool, Helminths drug effects, Middle Aged, Prevalence, Mass Drug Administration statistics & numerical data, Mass Drug Administration methods, Helminthiasis drug therapy, Helminthiasis prevention & control, Helminthiasis epidemiology, Helminthiasis transmission, Soil parasitology, Albendazole therapeutic use, Albendazole administration & dosage, Anthelmintics therapeutic use, Anthelmintics administration & dosage
- Abstract
Background: Soil-transmitted helminths (STH) affect approximately 1.5 billion people globally. The current STH control strategy is annual or twice-annual preventive chemotherapy, typically school-based deworming targeting children and women of reproductive age. Mathematical modeling suggests that it may be possible to interrupt STH transmission through high-coverage community-wide mass drug administration (cMDA). DeWorm3 is a cluster randomized trial testing cMDA for prevalence reduction and transmission interruption. The purpose of this study is to describe coverage of cMDA in study clusters over time and correlates of coverage at individual and cluster levels., Methods: From 2018-2020, DeWorm3 delivered six rounds of cMDA with 400 mg albendazole at sites in Benin, India, and Malawi. We report coverage, treatment uptake, and directly observed therapy across all rounds. Factors associated with coverage at the cluster level were identified using binomial generalized estimating equations, while factors associated with non-treatment at the individual level were identified using binomial mixed-effects models., Results: Coverage was high across all clusters and rounds, exceeding the WHO target of 75% in all sites and across all rounds (78% to 95%); cluster-level coverage tended to increase over time. Younger, unmarried, and migratory adults were more likely to be untreated at all sites; adult males were more likely to be untreated in Benin and Malawi. Among children, girls were more likely to be untreated, as were non-school-attending and migratory children. Higher adult education was associated with greater odds of non-treatment among adults, but lower odds among children in the household. Belonging to a less wealthy or minority language-speaking household was associated with non-treatment among both adults and children., Conclusions: It is possible to deliver community-wide MDA with high coverage. Unique individual and community-level factors influence treatment across settings, and these may be addressed through targeted programming., Trial Registration: Field Studies on the Feasibility of Interrupting the Transmission of Soil-transmitted Helminths (STH), NCT03014167., (© 2024. The Author(s).)
- Published
- 2024
- Full Text
- View/download PDF
106. Characterizing trachoma elimination using serology.
- Author
-
Kamau E, Ante-Testard PA, Gwyn S, Blumberg S, Abdalla Z, Aiemjoy K, Amza A, Aragie S, Arzika AM, Awoussi MS, Bailey RL, Butcher R, Callahan EK, Chaima D, Dawed AA, Saboyá Díaz MI, Domingo AS, Drakeley C, Elshafie BE, Emerson PM, Fornace K, Gass K, Goodhew EB, Hammou J, Harding-Esch EM, Hooper PJ, Kadri B, Kalua K, Kanyi S, Kasubi M, Kello AB, Ko R, Lammie PJ, Lescano AG, Maliki R, Masika MP, Migchelsen SJ, Nassirou B, Nesemann JM, Parameswaran N, Pomat W, Renneker K, Roberts C, Rymil P, Sata E, Senyonjo L, Seife F, Sillah A, Sokana O, Srivathsan A, Tadesse Z, Taleo F, Taylor EM, Tekeraoi R, Togbey K, West SK, Wickens K, William T, Wittberg DM, Yeboah-Manu D, Youbi M, Zeru T, Keenan JD, Lietman TM, Solomon AW, Nash SD, Martin DL, and Arnold BF
- Abstract
Trachoma is targeted for global elimination as a public health problem by 2030. Measurement of IgG antibodies in children is being considered for surveillance and programmatic decision-making. There are currently no guidelines for applications of serology, which represents a generalizable problem in seroepidemiology and disease elimination. We collated Chlamydia trachomatis Pgp3 and CT694 IgG measurements (63,911 children ages 1-9 years) from 48 serosurveys, including surveys across Africa, Latin America, and the Pacific Islands to estimate population-level seroconversion rates (SCR) along a gradient of trachoma endemicity. We propose a novel, generalizable approach to estimate the probability that population C. trachomatis transmission is below levels requiring ongoing programmatic action, or conversely is above levels that indicate ongoing interventions are needed. We provide possible thresholds for SCR at a specified level of certainty and illustrate how the approach could be used to inform trachoma program decision-making using serology., Competing Interests: KR, PJH, and PME are employees of, and EMHE receives salary support from, the International Trachoma Initiative, which receives an operating budget and research funds from Pfizer Inc., the manufacturers of Zithromax® (azithromycin). The other authors declare no competing interests. The authors alone are responsible for the views expressed in this article and they do not necessarily represent the views, decisions or policies of the institutions with which they are affiliated.
- Published
- 2024
- Full Text
- View/download PDF
107. Disability in childhood and the equity of health services: a cross-sectional comparison of mass drug administration strategies for soil-transmitted helminths in southern Malawi.
- Author
-
Witek-McManus S, Simwanza J, Msiska R, Mangawah H, Oswald W, Timothy J, Galagan S, Pearman E, Shaikh M, Legge H, Walson J, Juziwelo L, Davey C, Pullan R, Bailey RL, Kalua K, and Kuper H
- Subjects
- Humans, Malawi epidemiology, Child, Male, Female, Cross-Sectional Studies, Adolescent, Child, Preschool, Anthelmintics therapeutic use, Anthelmintics administration & dosage, Disabled Children, Prevalence, School Health Services, Helminthiasis drug therapy, Helminthiasis epidemiology, Soil parasitology, Mass Drug Administration
- Abstract
Background: School-based approaches are an efficient mechanism for the delivery of basic health services, but may result in the exclusion of children with disabilities if they are less likely to participate in schooling. Community-based 'door to door' approaches may provide a more equitable strategy to ensure that children with disabilities are reached, but disability is rarely assessed rigorously in the evaluation of health interventions., Objectives: To describe the prevalence and factors associated with disability among children aged 5-17 years and to assess the relative effectiveness of routine school-based deworming (SBD) compared with a novel intervention of community-based deworming (CBD) in treating children with disabilities for soil-transmitted helminths., Setting: DeWorm3 Malawi Site (DMS), Mangochi district, Malawi., Participants: All 44 574 children aged 5-17 years residing within the DMS., Primary and Secondary Outcome Measures: Disability was defined as a functional limitation in one or more domains of the Washington Group/UNICEF Child Functioning Module administered as part of a community-based census. Treatment of all children during SBD and CBD was independently observed and recorded. For both intervention types, we performed bivariate analyses (z-score) of the absolute proportion of children with and without disabilities treated (absolute differences (ADs) in receipt of treatment), and logistic regression to examine whether disability status was associated with the likelihood of treatment (relative differences in receipt of treatment)., Results: The overall prevalence of disability was 3.3% (n=1467), and the most common domains of disability were hearing, remembering and communication. Boys were consistently more likely to have a disability compared with girls at all age groups, and disability was strongly associated with lower school attendance and worse levels of education. There was no significant difference in the proportion of children with disabilities treated during SBD when assessed by direct observation (-1% AD, p=0.41) or likelihood of treatment (adjusted risk ratio (aRR)=1.07, 95% CI 0.89 to 1.28). Treatment of all children during CBD was substantially higher than SBD, but again showed no significant difference in the proportions treated (-0.5% AD, p=0.59) or likelihood of treatment (aRR=1.04, 95% CI 0.99 to 1.10)., Conclusion: SBD does not appear to exclude children with disabilities, but the effect of consistently lower levels of educational participation of children with disabilities should be actively considered in the design and monitoring of school health interventions., Trial Registration Number: NCT03014167., Competing Interests: Competing interests: None declared., (© Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY. Published by BMJ.)
- Published
- 2024
- Full Text
- View/download PDF
108. Etiologies of Infectious Keratitis in Malawi.
- Author
-
Kalua K, Misanjo ES, Lietman TM, Ruder K, Zhong L, Chen C, Liu Y, Yu D, Abraham T, Wu N, Yan D, Hinterwirth A, Doan T, and Seitzman GD
- Subjects
- Humans, Malawi epidemiology, Male, Adult, Female, Middle Aged, Corneal Ulcer microbiology, Corneal Ulcer epidemiology, Young Adult, Adolescent, Eye Infections, Fungal microbiology, Eye Infections, Fungal epidemiology, Aged, Fungi isolation & purification, Fungi classification, Bacteria isolation & purification, Bacteria classification, Cornea microbiology, Cornea pathology, Keratitis microbiology, Keratitis epidemiology
- Abstract
Infectious keratitis is a leading cause of corneal blindness worldwide with little information known about causative etiologies in Malawi, Africa. This area is resource-limited with ophthalmologist and microbiology services. The Department of Ophthalmology at the Kamuzu College of Health Sciences in Blantyre, Malawi, is a participating site of an international corneal ulcer consortium, capriCORN (Comprehensive Analysis of Pathogens, Resistomes, and Inflammatory-markers in the CORNea). In this study, 50 patients with corneal ulcers were swabbed for pathogen identification using RNA-sequencing. Corneal trauma was reported in 41% and 19% of the patients worked in agriculture. A pathogen was identified in 58% of the cases. Fungal pathogens predominated, followed by viruses and bacteria. Aspergillus, Fusarium, HSV-1, and Gardnerella were the most common pathogens detected. 50% of patients reported treatment with an antibiotic before presentation. Pathogens unusual for infectious keratitis, such as Subramaniula asteroids, Aureobasidium pullulans, and Gardnerella vaginalis, were also detected.
- Published
- 2024
- Full Text
- View/download PDF
109. Gender differences in the surgical management of trachomatous trichiasis: an exploratory analysis of global trachoma survey data, 2015-2019.
- Author
-
Sullivan KM, Harding-Esch EM, Batcho WE, Issifou AAB, Lopes MFC, Szwarcwald CL, Vaz Ferreira Gomez D, Bougouma C, Christophe N, Kabore M, Bucumi V, Bella AL, Epee E, Yaya G, Trujillo-Trujillo J, Dejene M, Gebretsadik FS, Gebru G, Kebede F, Mathewos T, Cassama ETS, Sanha S, Barasa E, Sultani HM, Watitu T, Tekeraoi R, Kalua KM, Masika MP, Traoré L, Minnih AO, Abdala M, Massangaie ME, Win Y, Apadinuwe SC, Mishra SK, Sharma S, Amza A, Kadri B, Nassirou B, Mpyet CD, Olobio N, Hussain A, Khan AA, Jambi G, Ko R, Kello AB, Badiane MD, Sarr B, Dalmar A, Elshafie BE, Kabona GE, Kaitaba O, Mwingira U, Simon A, Kanyi S, Awoussi MS, Togbey K, Baayenda G, Francis M, Tukahebwa EM, Bakhtiari A, Keil AP, Maselko J, Westreich D, Garae M, Taleo F, Al-Khateeb TQ, Mwale C, Solomon AW, and Gower EW
- Subjects
- Humans, Male, Female, Cross-Sectional Studies, Sex Factors, Risk Factors, Prevalence, Trichiasis epidemiology, Trichiasis surgery, Trichiasis etiology, Trachoma epidemiology, Trachoma surgery
- Abstract
Background: Trachomatous trichiasis (TT) is a painful, potentially blinding eye condition that can be managed through epilation or surgery. Women are affected by TT approximately twice as often as men and are believed to face gendered barriers to receiving surgical care to prevent vision loss., Methods: We used data from 817 cross-sectional surveys conducted during 2015-2019 in 20 African countries to estimate the prevalence difference (PD) between female and male eyes for four outcomes potentially indicating gender-related differences in TT management: (1) received surgery and developed postoperative TT (PTT), (2) never offered surgery, (3) offered surgery but declined it, and (4) offered epilation but never offered surgery., Results: The prevalence was modestly elevated among female eyes compared with male eyes for having PTT (PD:1.8 [95% confidence limits (CL): 0.6, 3.0]) and having declined surgery for the eye (PD: 6.2 [95% CL: 1.8, 10.7]). The proportion offered epilation was similar by gender (PD:0.5 [95% CL: -0.4, 1.3]), while never having been offered surgery was somewhat more prevalent among male eyes (PD: -2.1 [95% CL: -3.5, -0.7])., Conclusions: Our results suggest potential gender differences in TT management. More research is needed to determine the causes and implications of the observed differences., (© The Author(s) 2023. Published by Oxford University Press on behalf of Royal Society of Tropical Medicine and Hygiene.)
- Published
- 2023
- Full Text
- View/download PDF
110. Monitoring transmission intensity of trachoma with serology.
- Author
-
Tedijanto C, Solomon AW, Martin DL, Nash SD, Keenan JD, Lietman TM, Lammie PJ, Aiemjoy K, Amza A, Aragie S, Arzika AM, Callahan EK, Carolan S, Dawed AA, Goodhew EB, Gwyn S, Hammou J, Kadri B, Kalua K, Maliki R, Nassirou B, Seife F, Tadesse Z, West SK, Wittberg DM, Zeru Tadege T, and Arnold BF
- Subjects
- Child, Humans, Infant, Child, Preschool, Seroepidemiologic Studies, Antigens, Bacterial, Antibodies, Bacterial, Chlamydia trachomatis, Prevalence, Trachoma diagnosis, Trachoma epidemiology
- Abstract
Trachoma, caused by ocular Chlamydia trachomatis infection, is targeted for global elimination as a public health problem by 2030. To provide evidence for use of antibodies to monitor C. trachomatis transmission, we collated IgG responses to Pgp3 antigen, PCR positivity, and clinical observations from 19,811 children aged 1-9 years in 14 populations. We demonstrate that age-seroprevalence curves consistently shift along a gradient of transmission intensity: rising steeply in populations with high levels of infection and active trachoma and becoming flat in populations near elimination. Seroprevalence (range: 0-54%) and seroconversion rates (range: 0-15 per 100 person-years) correlate with PCR prevalence (r: 0.87, 95% CI: 0.57, 0.97). A seroprevalence threshold of 13.5% (seroconversion rate 2.75 per 100 person-years) identifies clusters with any PCR-identified infection at high sensitivity ( >90%) and moderate specificity (69-75%). Antibody responses in young children provide a robust, generalizable approach to monitor population progress toward and beyond trachoma elimination., (© 2023. The Author(s).)
- Published
- 2023
- Full Text
- View/download PDF
111. Prevalence and risk factors for trachoma in central and southern Malawi.
- Author
-
Kalua K, Chirwa T, Kalilani L, Abbenyi S, Mukaka M, and Bailey R
- Subjects
- Adolescent, Adult, Child, Child, Preschool, Cross-Sectional Studies, Data Collection methods, Female, Geography, Humans, Infant, Logistic Models, Malawi epidemiology, Male, Multivariate Analysis, Prevalence, Risk Factors, Trachoma diagnosis, Trachoma epidemiology
- Abstract
Background: Trachoma, one of the neglected tropical diseases is suspected to be endemic in Malawi., Objectives: To determine the prevalence of trachoma and associated risk factors in central and southern Malawi., Methodology/principal Findings: A population based survey conducted in randomly selected clusters in Chikwawa district (population 438,895), southern Malawi and Mchinji district (population 456,558), central Malawi. Children aged 1-9 years and adults aged 15 and above were assessed for clinical signs of trachoma. In total, 1010 households in Chikwawa and 1016 households in Mchinji districts were enumerated within 108 clusters (54 clusters in each district). A total of 6,792 persons were examined for ocular signs of trachoma. The prevalence of trachomatous inflammation, follicular (TF) among children aged 1-9 years was 13.6% (CI 11.6-15.6) in Chikwawa and 21.7% (CI 19.5-23.9) in Mchinji districts respectively. The prevalence of trachoma trichiasis (TT) in women and men aged 15 years and above was 0.6% (CI 0.2-0.9) in Chikwawa and 0.3% (CI 0.04-0.6) in Mchinji respectively. The presence of a dirty face was significantly associated with trachoma follicular (TF) in both Chikwawa and Mchinji districts (P<0.001)., Conclusion/significance: Prevalence rates of trachoma follicles (TF) in Central and Southern Malawi exceeds the WHO guidelines for the intervention with mass antibiotic distribution (TF>10%), and warrants the trachoma SAFE control strategy to be undertaken in Chikwawa and Mchinji districts.
- Published
- 2010
- Full Text
- View/download PDF
112. Use of key informants in determining the magnitude and causes of childhood blindness in Chikwawa district, southern Malawi.
- Author
-
Kalua K
- Published
- 2007
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.